Clinipace Worldwide Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Clinipace Worldwide Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6466
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clinipace Worldwide Inc (Clinipace), formerly Clinipace Inc is a contract research organization that offers drug and medical devices development services. The organization’s services include manufacturing and control, chemistry, biostatistics, clinical monitory, data management, global study feasibility, GCP training, medical affairs and writing services. It also provides site selection and management, project management, pharmacokinetic and pharmacodynamic studies, and regulatory affairs services, among others. Clinipace offers its services in therapeutic areas such as pain, ophthalmology, dermatology, infectious disease, vaccines, rheumatology, oncology, and other cell and tissue based therapies. The organization operates in partnership with research centers for its clinical research activities. It has its operations in the Americas, Europe, Asia Pacific, and the Middle East. Clinipace is headquartered in Morrisville, North Carolina, the US.

Clinipace Worldwide Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinipace Worldwide Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinipace Worldwide Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clinipace Worldwide Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Clinipace Raises USD3 Million in Venture Financing 10
Clinipace Raises USD3.7 Million in Venture Financing 11
Clinipace Worldwide Raises USD50 Million in Venture Financing 12
Clinipace Raises USD4 Million in Venture Financing 13
Clinipace Raises US$3 Million In Venture Financing 14
Clinipace Worldwide Raises US$9 Million In Venture Financing 15
Clinipace Raises US$13 Million In Venture Financing 16
Clinipace Worldwide Inc – Key Competitors 17
Clinipace Worldwide Inc – Key Employees 18
Clinipace Worldwide Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Corporate Communications 21
May 10, 2018: Clinipace Worldwide Names Charlene Dark Vice President, Global Clinical Analytics 21
Oct 27, 2017: Clinipace Worldwide Executive Joins Board of Kidney Health Initiative 22
Oct 17, 2017: Clinipace Worldwide Co-founder & CEO Jeff Williams to Resign as CEO 23
Aug 31, 2017: Clinipace Worldwide Adds Industry Veteran Steve Skolsky to Board of Directors 24
Aug 07, 2017: Clinipace Worldwide Appoints Nikolas Burlew To Head Up New RSD Global Consulting Group 25
May 18, 2017: Clinipace Worldwide Hires Nephrologist Eric B. Grossman, MD, as Vice President and Medical Director 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Clinipace Worldwide Inc, Medical Equipment, Key Facts 2
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinipace Worldwide Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinipace Worldwide Inc, Deals By Market, 2012 to YTD 2018 8
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clinipace Raises USD3 Million in Venture Financing 10
Clinipace Raises USD3.7 Million in Venture Financing 11
Clinipace Worldwide Raises USD50 Million in Venture Financing 12
Clinipace Raises USD4 Million in Venture Financing 13
Clinipace Raises US$3 Million In Venture Financing 14
Clinipace Worldwide Raises US$9 Million In Venture Financing 15
Clinipace Raises US$13 Million In Venture Financing 16
Clinipace Worldwide Inc, Key Competitors 17
Clinipace Worldwide Inc, Key Employees 18
Clinipace Worldwide Inc, Other Locations 19
Clinipace Worldwide Inc, Subsidiaries 20

List of Figures
Clinipace Worldwide Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinipace Worldwide Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinipace Worldwide Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Clinipace Worldwide Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TDC AS (TDC):企業の財務・戦略的SWOT分析
    TDC AS (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Harry Ramsden’s:企業の戦略・SWOT・財務分析
    Harry Ramsden's - Strategy, SWOT and Corporate Finance Report Summary Harry Ramsden's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Advanced BioScience Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract manufacturing company that provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. The company …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Diplomat Pharmacy Inc (DPLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • LifeNet Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeNet Health Inc (LifeNet Health) is a non-profit organization that specializes in regenerative medicine. It offers allograft bio-implants and organs for transplantation. The organization specializes in offering organ procurement, tissue banking and transplant services. It provides allogra …
  • China Huaneng Group:電力:M&Aディール及び事業提携情報
    Summary China Huaneng Group (CHNG) is a state-owned power generation company. It invests, develops, constructs, operates and manages power sources in China. The company develops coal-fired, hydro, wind, solar, nuclear and natural gas-fired power projects. CHNG also involved in the development, inves …
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Chong Kun Dang Pharmaceutical Corp (185750):製薬・医療:M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Rockwell Automation Inc (ROK):企業の財務・戦略的SWOT分析
    Rockwell Automation Inc (ROK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Delaware North Companies Inc:企業の戦略的SWOT分析
    Delaware North Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Alliant Energy Corporation (LNT)-エネルギー分野:企業M&A・提携分析
    Summary Alliant Energy Corporation (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisc …
  • MTN Group Ltd (MTN):企業の財務・戦略的SWOT分析
    MTN Group Ltd (MTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆